Clinical trial
Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer
NCT00209703 · Hokkaido Gastrointestinal Cancer Study Group, Other · Terminated
Key facts
| NCT number | NCT00209703 |
|---|---|
| Title | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer |
| Official title | Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, l-Leucovorin, 5-Fluorouracil |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 21, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: